Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the control of obesity. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://emilielmix252041.targetblogs.com/39356464/retaglutide-a-promising-glp-1-receptor-agonist